CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


<
Tg Therapeutics, Inc.  (TGTX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare


 

Tg Therapeutics, Inc.

TGTX's Financial Statements and Analysis






Tg Therapeutics, Inc. increased II. Quarter net loss per share of $-0.59 compare to net loss per share of $-0.45 recorded in the same quarter a year ago a decrease compare to $-0.59 realized in previous quarter.

Tg Therapeutics's Revenue fell by % in II. Quarter (Jun 30 2018) year on year, to $0 million and declined by 0 % sequentially.


Tg Therapeutics is
More on TGTX's Income Statement

II. Quarter
Earnings Per Share Revenues
$ -0.59 $  0 Mill
$-0.14     Unch.     -0.25 %
You need to upgrade your Flash Player
TGTX's NET INCOME

Tg Therapeutics's in II. Quarter recorded net loss of $-44 million, an increase from net loss of $-28 million in II. Quarter a year ago.

Sequentially net loss advanced

More on TGTX's Growth

TGTX's Cash flow In II. Quarter company's net cash flow was $23 million, capital expenditures fell by 1,426.72%, to $-0 millions compare to same quarter a year ago and fell by 41.67% from I. Quarter (Mar 31 2018).

More on TGTX's Cash flow Statement



Tg Therapeutics, Inc. does not pay out common stock dividend.

In trailing twelve-month period Tg Therapeutics, Inc. payed $ -1.44 cash per share, on a free-cash flow basis .

Book value grew by 13.14 % sequentially to $1.37 per share.
Tangible Book value grew to $ 1.35 per share from $ 1.20.

Company issued 3.62 million shares or 5.12 % in II. Quarter.


More on TGTX's Dividends
 Market Capitalization (Millions) 854
 Shares Outstanding (Millions) 74
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -148
 Cash Flow (TTM) (Millions $) 29
 Capital Exp. (TTM) (Millions $) -0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -





Tg Therapeutics, Inc. does not pay out common stock dividend.

In trailing twelve-month period Tg Therapeutics, Inc. payed $ -1.44 cash per share, on a free-cash flow basis .

Book value grew by 13.14 % sequentially to $1.37 per share.
Tangible Book value grew to $ 1.35 per share from $ 1.20.

Company issued 3.62 million shares or 5.12 % in II. Quarter.


More on TGTX's Dividends
 Market Capitalization (Millions) 854
 Shares Outstanding (Millions) 74
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -148
 Cash Flow (TTM) (Millions $) 29
 Capital Exp. (TTM) (Millions $) -0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ALYE's Profile

Stock Price

ALYE's Financials

Business Description

Fundamentals

Charts & Quotes

ALYE's News

Suppliers

ALYE's Competitors

Customers & Markets

Economic Indicators

ALYE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071